Member Info for rbr08

Genedrive Dossier Review still 'In process'

https://www.who.int/diagnostics_laboratory/200929_eul_covid19_ivd_update.pdf?ua=1

Abbott together with Bill and Melinda Gates fund to provide 120million tests for developing nations. I wonder what the status of our POC system?

@Invest4theLT
https://www.genedrive.com/documents/ID-COV2-IFU-09-EN.pdf

How do you know InterTrader is a shorter?

@PP.... wont say your getting carried away. Its a plausible option to be fair.
Just at whats the highest value DB and the board can get. Hoping for +250M

Hoping for some solid improvements on the motor side of operations....

Would be nice, if we just had a bit of comms. Even a neutral statement. Ive just got a bit more defensive over the last few weeks, but like everyone else Im really hoping for some update/RNS

...should be another acceptable results

With all due respect, please continue your AMGO chat on the AMGO bb....

@maxage, BOO has a trading update beginning of Sept? Their interim results are set for 30 Sept

@Magsy18 as I said, I'm not seeking any crystal ball reader. For me a ramper without facts/ calculations etc is just that. And these are the ones I simply ignore. I accept that we are all never going to agree on particulars but that's not the point. The point is to get a good understanding of how other investors are thinking. I accept your conclusion that 2/share is do-able and your first target - there after you may only be able o better judge at a later point. And fair enough.

In my original post I did mention @technick as well as I value his knowledge in pharma.

Finally, everyday is a learning day. The day you think you know it all and no longer value others, will be your darkest day!!
So I value all well constructed opinions,

I'm not trying to justify any position. What I accept is that there are more experienced individuals both in terms of investing and knowledge of the pharma industry. I accept both the low and high Mcap valuations but the more important aspect for me is being able to understand both ends of the spectrum and not to simply get a response that suits a particular value.
Do i think we are undervalued - YES. Do I know the full potential of this company - I DONT THINK SO. But I believe that 2+ is possible - beyond this value is where my experience and knowledge is lacking. Many variables at play including the buy-out option.

I'm here to simply to learn and take part in constructive and informative discussions(ignoring fully committed rampers and de-rampers). Just my 2 cents!

@bigAI67: your calculations only factor in Covid side of GDRs portofilio. But there is also:
1) Hepatitis C (HCV) Genedrive® HCV ID Kit --- think the value of this may already be realised in current MCap as its more competitive field

2) Antibiotic Induced Hearing Loss test, the Genedrive MT-RNR1 ID kit --- Im not sure about sales status but from what I know we are the only one in the market with such technology

So can one argue, that your 300M MCap is on top of current MCap of 50M???

@bigbench @technick --- thoughts?

@technik and @bigbench what are your thoughts now on potential value now of GDR - since BC partnership, continued delay on sales in a thriving market and continued increase competition.

I'm relatively new to the pharma stocks, and previously seeing suggestions of 300million. With our relatively smaller Shares in circulation we are looking at 5-6£

Does the BC deal temporarily remove any chance of a placing? Many were saying this company now has a min. MCap of 300Million.... current shares x $5.78.

What is your view now? I'm not sure if we consider a buy-out from BC we will be offered such. I think slightly lower. THOUGHTS??!!!

at what price, though?

....thoughts?

As expected. Seeing some improvements month on month (June - July) and (+) cash balance.

...at what price though? Its incredible whats happened with this share price!!

28th July
http://www.foxtonsgroup.co.uk/investors/financial-calendar/